ZNF185 Activators belong to a chemical class of compounds designed to modulate the activity of the Zinc Finger Protein 185 (ZNF185). ZNF185 is a member of the C2H2-type zinc finger protein family, which is characterized by the presence of multiple zinc finger domains that facilitate DNA binding and gene regulation. These proteins play a pivotal role in gene expression by recognizing specific DNA sequences and modulating transcriptional activity. ZNF185, in particular, is known to be involved in transcriptional regulation, where it can act as both a transcriptional activator and repressor depending on the context and the target genes it interacts with.
Activators within the ZNF185 chemical class are developed to enhance the transcriptional activation or repressive properties of ZNF185. By manipulating ZNF185's activity, researchers can investigate its role in regulating specific genes and cellular processes. This provides valuable insights into the molecular mechanisms that underlie gene expression, which is fundamental for understanding various biological processes, including development, differentiation, and responses to environmental signals. Additionally, ZNF185 Activators have the potential to be used in the laboratory to explore gene regulation and to develop tools for gene manipulation and research. Understanding the function of ZNF185 and its interaction with target genes is crucial for unraveling the complexities of gene regulation in both normal and disease states.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid, involved in cell differentiation, might influence ZNF185 expression in pathways related to development and cancer. | ||||||
Thymosin β4 | 77591-33-4 | sc-396076 sc-396076A | 1 mg 100 mg | $134.00 $7140.00 | ||
TGF-β, involved in cellular processes such as proliferation and differentiation, might modulate ZNF185 expression in various tissues. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
As a DNA methyltransferase inhibitor, this compound could influence ZNF185 expression by altering DNA methylation patterns. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $256.00 | 18 | |
Tamoxifen, known to interact with estrogen receptors, might influence ZNF185 expression in hormone-responsive tissues. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
As a glucocorticoid, dexamethasone could affect ZNF185 expression in stress response pathways. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium, used in neurological studies, might modulate ZNF185 expression through signaling pathways involved in neurobiology. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin, which elevates cAMP levels, could influence ZNF185 expression through cAMP-dependent signaling pathways. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $70.00 $160.00 $290.00 | 2 | |
Vitamin D3, involved in cell growth and immune function, might affect ZNF185 expression in immune and epithelial cells. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin, known for its anti-inflammatory properties, might modulate ZNF185 expression in pathways related to inflammation and cancer. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
Sulforaphane, a compound found in cruciferous vegetables, could influence ZNF185 expression, potentially in cancer-related pathways. |